Herbergs J, Hopman A H, De Bruïne A P, Ramaekers F C, Arends J W
Department of Pathology, University Hospital Maastricht, The Netherlands.
J Pathol. 1996 Jul;179(3):243-7. doi: 10.1002/(SICI)1096-9896(199607)179:3<243::AID-PATH588>3.0.CO;2-Q.
Chromosomal aberrations in colonic tumourigenesis were investigated by fluorescence in situ hybridization (FISH) with centromere-specific DNA probes and correlated to flow cytometry (FCM) results in a series of tissues including normal colonic epithelium, adenomas, and carcinomas, as well as adenomas adjacent to carcinomas. No numerical chromosome aberrations were detected in normal colonic epithelium, except for an extra chromosome X in one case. In the adenomas, the most frequently occurring chromosome aberration was a trisomy for chromosome 7, occurring in 37 per cent of the cases. In the carcinomas, two distinct routes of genetic aberration could be established on the basis of correlation with FCM: one with and one without endoreduplication. In the carcinomas without endoreduplication, trisomy or tetrasomy for chromosome 7 was detected in 12 out of 15 cases (80 per cent). In three of these cases, trisomy 7 was found in combination with loss of chromosome 17 and/or chromosome 18. In 87 per cent of the carcinomas with endoreduplication, loss of chromosome 17 and/or 18 was found, while in only one case was gain of chromosome 7 detected. In the adenomas adjacent to carcinomas, trisomy 7 was found in 36 per cent of the cases. In these cases, the concomitant adenocarcinomas showed the same numerical chromosome 7 aberration, plus extra aberrations for other chromosomes. In only two cases the carcinoma demonstrated trisomy 7 with a normal adjacent adenoma. These results suggest that gain of chromosome 7 is a significant aberration in the tumourigenesis of colonic carcinomas in which no endoreduplication has occurred. No marked clinico-pathological differences were observed between tumours of either route of tumourigenesis in this series.
采用着丝粒特异性DNA探针,通过荧光原位杂交(FISH)技术研究结肠肿瘤发生过程中的染色体畸变,并将其与一系列组织(包括正常结肠上皮、腺瘤、癌以及癌旁腺瘤)的流式细胞术(FCM)结果相关联。在正常结肠上皮中,除1例出现额外的X染色体外,未检测到染色体数目畸变。在腺瘤中,最常见的染色体畸变是7号染色体三体,发生率为37%。在癌组织中,根据与FCM的相关性可确定两种不同的遗传畸变途径:一种有核内复制,一种无核内复制。在无核内复制的癌组织中,15例中有12例(80%)检测到7号染色体三体或四体。其中3例中,7号染色体三体与17号和/或18号染色体缺失同时存在。在有核内复制的癌组织中,87%发现17号和/或18号染色体缺失,而仅1例检测到7号染色体增加。在癌旁腺瘤中,36%的病例发现7号染色体三体。在这些病例中,与之相伴的腺癌显示出相同的7号染色体数目畸变,以及其他染色体的额外畸变。仅2例癌组织显示7号染色体三体,而相邻腺瘤正常。这些结果表明,7号染色体增加是未发生核内复制的结肠癌肿瘤发生过程中的一种重要畸变。在本系列中,这两种肿瘤发生途径的肿瘤之间未观察到明显的临床病理差异。